https://scholars.lib.ntu.edu.tw/handle/123456789/580325
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | YU-YUN SHAO | en_US |
dc.contributor.author | ZHONG-ZHE LIN | en_US |
dc.contributor.author | PO-CHIN LIANG | en_US |
dc.contributor.author | YU-WEN TIEN | en_US |
dc.contributor.author | ANN-LII CHENG | en_US |
dc.date.accessioned | 2021-09-01T01:54:22Z | - |
dc.date.available | 2021-09-01T01:54:22Z | - |
dc.date.issued | 2009 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650083184&partnerID=40&md5=50f7a6348add00d04c5342cb205cef22 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/580325 | - |
dc.description.abstract | Bowel perforation is a rare but life-threatening complication of bevacizumab, a new anticancer treatment. Patients with bowel perforation usually present with acute abdominal symptoms. Here a case history is presented to highlight a pancreatic cancer patient on bevacizumab chemotherapy who developed empyema as the first manifestation of gastric perforation. This unusual presentation warns physicians that bevacizumab-related bowel perforation can arise as a thoracic complication, without typical gastrointestinal manifestations, in an advanced cancer patient. | en_US |
dc.relation.ispartof | Anticancer Research | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | antineoplastic agent; bevacizumab; cefepime; cetuximab; adult; advanced cancer; article; cancer patient; cancer therapy; case report; clinical feature; computer assisted tomography; dyspnea; empyema; fever; human; male; pancreas abscess; pancreas cancer; priority journal; stomach perforation; thorax radiography; Antibodies, Monoclonal; Antineoplastic Agents; Empyema; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, X-Ray Computed | - |
dc.title | Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment | en_US |
dc.type | journal article | en |
dc.identifier.pmid | 19443383 | - |
dc.identifier.scopus | 2-s2.0-67650083184 | - |
dc.relation.pages | 1665-1667 | en_US |
dc.relation.journalvolume | 29 | en_US |
dc.relation.journalissue | 5 | en_US |
item.fulltext | no fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Medical Service-NTUCC | - |
crisitem.author.dept | Medical Oncology-NTUCC | - |
crisitem.author.dept | Center for Quality Management and Infection Control-NTUCC | - |
crisitem.author.dept | Radiology | - |
crisitem.author.dept | Medical Imaging-NTUH | - |
crisitem.author.dept | Medical Imaging-NTUHHC | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.orcid | 0000-0001-7334-1912 | - |
crisitem.author.orcid | 0000-0002-6674-2926 | - |
crisitem.author.orcid | 0000-0002-9126-2705 | - |
crisitem.author.orcid | 0000-0002-9152-6512 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。